Korea’s Next Policy Momentum Play: Rapid Unfolding of the National Growth Fund
This post flags Korea’s upcoming policy driver—the swift activation of the National Growth Fund—which is set to be a major catalyst for market...
574 Views
Genoray IPO Preview (Part 2) - Valuation Analysis
We are positive on the Genoray IPO. Our one year price target of the company is 25,944 won, which would represent nearly 27% higher than the high...
325 Views
Ildong Pharmaceutical Spin-Off:Â A Special Situations Gem
Ildong Pharmaceutical Co., Ltd. (000230 KS) spin-off is a special situations gem. We expect the combined values of Ildong Pharmaceutical and...
769 Views
No more insights